Julie Clary is a Cardiology physician affiliated with Indiana University. OpenAlex indexes 27 publications with 283 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1801 N Senate Blvd
Mpc 2, Suite 4000
Indianapolis, IN 462021228
Telephone
317-962-0500Provider last certified this registry record 30 Jul 2025.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Roche Diagnostics CorporationProgram year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20241 payment
- Regeneron Healthcare Solutions, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
92.6%Statin22.6%Atorvastatin Calcium55%Rosuvastatin Calcium34%Pravastatin Sodium10%Part D<11 patientsPCSK9 Inhibitor18.4%Repatha Sureclick75%Praluent Pen25%Part D<11 patients+ 12 more classes in this area
Blood & clotting
7.4%P2Y12 inhibitor4.6%Clopidogrel56%Brilinta44%Part D<11 patientsFactor Xa inhibitor2.8%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Rethinking familial hypercholesterolemia screening: Quantifying missed diagnoses at the intersection of genetic testing and lipoprotein(a)
American Journal of Preventive Cardiology
2026 - Predicting Mortality in Patients Hospitalized With Acute Myocardial Infarction: From the National Cardiovascular Data Registry
Circulation Cardiovascular Quality and Outcomes
2025 - Experiences of people with elevated lipoprotein(a) and the impact on family and child screening
Journal of clinical lipidology
2025 - PREDICTING IN-HOSPITAL MORTALITY IN PATIENTS HOSPITALIZED WITH ACUTE MYOCARDIAL INFARCTION: A REPORT FROM THE NCDR CHEST PAIN-MYOCARDIAL INFARCTION REGISTRY
Journal of the American College of Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Munro Peacock, MD
Indiana University
John Wo, MD
Indiana University
Homer Twigg, MD
Indiana University
Mithilesh Das, MD
Indiana University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”